Related Experiment Video

Updated: Jun 4, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.2K

Development and efficacy of mobile application to improve medication adherence for persons with cardiac disease

Raziyeh Ghafouri1, Roxana Karbaschi2, AliReza Mashhadi Hosein3

  • 1Department of Medical Surgical Nursing, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

ARYA Atherosclerosis
|December 19, 2024
PubMed

Insights

A new mobile app effectively improved medication adherence in heart patients. This intervention demonstrated significant benefits in patient compliance with treatment plans post-discharge.

Area of Science:

  • Cardiology
  • Digital Health
  • Health Informatics

Background:

  • Cardiovascular disease (CVD) management requires strict adherence to treatment plans.
  • Poor medication adherence exacerbates CVD progression and reduces quality of life.
  • Developing innovative tools is crucial for supporting patient self-management in cardiac care.

Purpose of the Study:

  • To develop a mobile application tailored for patients with cardiac disease.
  • To evaluate the efficacy of this mobile application in enhancing medication adherence.
  • To assess the impact of the application on patient compliance with treatment recommendations.

Main Methods:

  • The study utilized a two-stage approach, including mobile application development via the cascade model.
  • 121 hospitalized cardiac patients were recruited and randomized into intervention (n=58) and control (n=63) groups.
  • Medication adherence was assessed using a questionnaire on days 7, 14, and 21 post-discharge, with data analyzed using SPSS 20.

Main Results:

  • No significant age difference was observed between the intervention (57.03 ± 11.55 years) and control (56.75 ± 11.38 years) groups.
  • The intervention group showed significantly higher medication adherence on days 7, 14, and 21 post-discharge compared to the control group (P<0.01).
  • Repeated measures analysis indicated a significant increase in adherence over time within the intervention group (P<0.001).

Conclusions:

  • The developed mobile application is effective in improving medication adherence among patients with cardiac disease.
  • Digital health interventions show promise for enhancing patient compliance in chronic disease management.
  • This mobile tool can support cardiovascular patients in adhering to their prescribed treatment regimens.
Abstract

Keywords:
EffectivenessHeart DiseaseMedication AdherenceMobile Applications

More Related Videos

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

11.5K
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

709

Related Concept Videos

Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
38
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
759
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
382
Holter Monitor: 24-Hour Monitoring01:23

Holter Monitor: 24-Hour Monitoring

Holter monitoring is a continuous electrocardiography (ECG) recording that tracks the heart's electrical activity over an extended period, generally 24 to 48 hours. This noninvasive diagnostic tool detects irregular heart rhythms that may not be captured during a standard ECG performed in a clinical setting.DeviceThe Holter monitor is a portable, small device connected to several electrodes on the patient's chest. These electrodes detect the heart's electrical signals and transmit them to the...
2
Heart Failure Drugs: &#946;-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
315
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
516